Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2006-10-17
2006-10-17
Habte, Kahsay (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C514S256000, C514S316000, C514S318000, C544S295000, C544S296000, C544S333000, C544S357000, C546S192000, C546S193000, C546S194000, C546S242000, C546S247000
Reexamination Certificate
active
07122551
ABSTRACT:
Compounds of the formula Iuseful as metalloproteinase inhibitors, especially as inhibitors of MMP 13.
REFERENCES:
patent: 5998412 (1999-12-01), Broka et al.
patent: 6100266 (2000-08-01), Montana et al.
patent: 6130220 (2000-10-01), Broka et al.
patent: 6143744 (2000-11-01), Broka et al.
patent: 6235786 (2001-05-01), Dai et al.
patent: 6294573 (2001-09-01), Curtin et al.
patent: 6376506 (2002-04-01), Broka et al.
patent: 6479502 (2002-11-01), Martin
patent: 6482827 (2002-11-01), Alpegiani
patent: 2003/0050310 (2003-03-01), Martin
patent: 19802350 (1998-07-01), None
patent: WO-98/16514 (1998-04-01), None
patent: WO-99/02510 (1999-01-01), None
patent: WO-99/38843 (1999-08-01), None
Barlaam Bernard Christophe
Dowell Robert Ian
Finlay Maurice Raymond Verschoyle
Newcombe Nicholas John
Tucker Howard
AstraZeneca AB
Fish & Neave IP Group Ropes & Gray LLP
Habte Kahsay
LandOfFree
Metalloproteinase inhibitor compounds does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Metalloproteinase inhibitor compounds, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Metalloproteinase inhibitor compounds will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3696348